Advertisement

HIV Pre-exposure Prophylaxis Program Implementation Using Intervention Mapping

Published:February 09, 2018DOI:https://doi.org/10.1016/j.amepre.2017.12.015

      Introduction

      HIV pre-exposure prophylaxis has been proven to be an effective tool in HIV prevention. However, numerous barriers still exist in pre-exposure prophylaxis implementation.

      Methods

      The framework of Intervention Mapping was used from August 2016 to October 2017 to describe the process of adoption, implementation, and maintenance of an HIV prevention program from 2012 through 2017 in Houston, Texas, that is nested within a county health system HIV clinic. Using the tasks outlined in the Intervention Mapping framework, potential program implementers were identified, outcomes and performance objectives established, matrices of change objectives created, and methods and practical applications formed.

      Results

      Results include the formation of three matrices that document program outcomes, change agents involved in the process, and the determinants needed to facilitate program adoption, implementation, and maintenance. Key features that facilitated successful program adoption and implementation were obtaining leadership buy-in, leveraging existing resources, systematic evaluation of operations, ongoing education for both clinical and nonclinical staff, and attention to emergent issues during launch.

      Conclusions

      The utilization of Intervention Mapping to delineate the program planning steps can provide a model for pre-exposure prophylaxis implementation in other settings.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baeten J.M.
        • Donnell D.
        • Ndase P.
        • et al.
        Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
        N Engl J Med. 2012; 367: 399-410https://doi.org/10.1056/NEJMoa1108524
        • Thigpen M.C.
        • Kebaabetswe P.M.
        • Paxton L.A.
        • et al.
        Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
        N Engl J Med. 2012; 367: 423-434https://doi.org/10.1056/NEJMoa1110711
        • Grant R.M.
        • Lama J.R.
        • Anderson P.L.
        • et al.
        Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
        N Engl J Med. 2010; 363: 2587-2599https://doi.org/10.1056/NEJMoa1011205
        • Choopanya K.
        • Martin M.
        • Suntharasamai P.
        • et al.
        Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
        Lancet. 2013; 381: 2083-2090https://doi.org/10.1016/S0140-6736(13)61127-7
        • Grohskopf L.A.
        • Chillag K.L.
        • Gvetadze R.
        • et al.
        Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.
        J Acquir Immune Defic Syndr. 2013; 64: 79-86https://doi.org/10.1097/QAI.0b013e31828ece33
        • Marcus J.L.
        • Volk J.E.
        • Pinder J.
        • et al.
        Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings.
        Curr HIV/AIDS Rep. 2016; 13: 116-124https://doi.org/10.1007/s11904-016-0308-x
        • Liu A.Y.
        • Cohen S.E.
        • Vittinghoff E.
        • et al.
        Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.
        JAMA Intern Med. 2016; 176: 75-84https://doi.org/10.1001/jamainternmed.2015.4683
        • Laufer F.N.
        • O’Connell D.A.
        • Feldman I.
        • Zucker H.A.
        Vital signs: increased Medicaid prescriptions for preexposure prophylaxis against HIV infection—New York, 2012–2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1296-1301https://doi.org/10.15585/mmwr.mm6446a5
        • Smith D.K.
        • Van Handel M.
        • Wolitski R.J.
        • et al.
        Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1291-1295https://doi.org/10.15585/mmwr.mm6446a4
        • Silapaswan A.
        • Krakower D.
        • Mayer K.H.
        Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care.
        J Gen Intern Med. 2017; 32: 192-198https://doi.org/10.1007/s11606-016-3899-4
        • Zwerver F.
        • Schellart A.J.
        • Anema J.R.
        • Rammeloo K.C.
        • van der Beek A.J.
        Intervention mapping for the development of a strategy to implement the insurance medicine guidelines for depression.
        BMC Public Health. 2011; 11: 9https://doi.org/10.1186/1471-2458-11-9
        • van Bokhoven M.A.
        • Kok G.
        • van der Weijden T.
        Designing a quality improvement intervention: a systematic approach.
        Qual Saf Health Care. 2003; 12: 215-220https://doi.org/10.1136/qhc.12.3.215
        • Suzuki R.
        • Peterson J.J.
        • Weatherby A.V.
        • et al.
        Using intervention mapping to promote the receipt of clinical preventive services among women with physical disabilities.
        Health Promot Pract. 2012; 13: 106-115https://doi.org/10.1177/1524839910382624
        • Durks D.
        • Fernandez-Llimos F.
        • Hossain L.N.
        • Franco-Trigo L.
        • Benrimoj S.I.
        • Sabater-Hernandez D.
        Use of intervention mapping to enhance health care professional practice: a systematic review.
        Health Educ Behav. 2017; 44: 524-535https://doi.org/10.1177/1090198117709885
        • Bartholomew Eldredge L.K.
        • Markham C.M.
        • Ruiter R.A.C.
        • Fernandez M.E.
        • Kok G.
        • Parcel G.S.
        Planning Health Promotion Programs: An Intervention Mapping Approach. 4th ed. Jossey-Bass, San Francisco, CA2016
        • Carey M.P.
        • Schroder K.E.
        Development and psychometric evaluation of the brief HIV Knowledge Questionnaire.
        AIDS Educ Prev. 2002; 14: 172-182https://doi.org/10.1521/aeap.14.2.172.23902
        • Fisher J.D.
        • Fisher W.A.
        • Misovich S.J.
        • Kimble D.L.
        • Malloy T.E.
        Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population.
        Health Psychol. 1996; 15: 114-123https://doi.org/10.1037/0278-6133.15.2.114
        • Rivet Amico K.
        A situated-Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB-CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions.
        J Health Psychol. 2011; 16: 1071-1081https://doi.org/10.1177/1359105311398727
      1. Flash CA, Arya M, Amspoker AB, et al. Houston primary care providers’ perceptions of and willingness to prescribe HIV pre-exposure prophylaxis. Paper presented at: 9th International Conference on HIV Treatment and Prevention Adherence; June 8-10, 2014; Miami, FL.

        • Krakower D.
        • Ware N.
        • Mitty J.A.
        • Maloney K.
        • Mayer K.H.
        HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.
        AIDS Behav. 2014; 18: 1712-1721https://doi.org/10.1007/s10461-014-0839-3